References

Andrade, A. T., & Pizarro Orchard, E. (1987). Quantitative studies on menstrual blood loss in IUD users. Contraception, 36(1), 129-144.

Arnal, N., de Alaniz, M.J., and Marra, C.A. (2010) Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380A. Toxicol Lett 192(3), 373-378.

Azko Nobel. (2005). Azko Nobel Annual Report 2004.

Brian, J. V., Harris, C. A., Scholze, M., Backhaus, T., Booy, P., Lamoree, M., et al. (2005). Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ Health Perspect, 113(6), 721-728.

Bulatao, R. (2002). What Influences the Private Provision of Contraceptives? (No. 2). Washington, D.C.

CDC. (2005, November 4, 2005). Breastfeeding: Data and Statistics: Breastfeeding Practices — Results from the 2004 National Immunization Survey. Retrieved January 11, 2006.

Chaker, A. M. (2005, November 22). Doctors Back Off Birth-Control Patch. After FDA Warning on Excessive Hormones, Some Stop Prescribing Method; Weighing Choices. The Wall Street Journal, p. D1.

Clark, M. K., Sowers, M. R., Nichols, S., & Levy, B. (2004). Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril, 82(6), 1580-1586.

Colborn, T., Dumanoski, D., & Myers, J. P. (1997). Our stolen future: are we threatening our fertility, intelligence, and survival? a scientific detective story: with a new epilogue by the authors. New York: Penguin Group.

De la Cruz, D., Cruz, A., Arteaga, M., Castillo, L., & Tovalin, H. (2005). Blood copper levels in Mexican users of the T380A IUD. Contraception, 72(2), 122-125.

Diani, H. (2005, December 14, 2005). RI under threat of 'lost generation'. The Jakarta Post.

Diaz, J., Bahamondes, L., Monteiro, I., Petta, C., Hildalgo, M. M., & Arce, X. E. (2000). Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception, 62(2), 59-61.

Dieben, T. O., Roumen, F. J., & Apter, D. (2002). Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol, 100(3), 585-593.

Dubuisson, J. B., & Mugnier, E. (2002). Acceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: results of a French clinical study in women aged 35 to 45 years. Contraception, 66(2), 121-128.

Foreit, K. G. (1999). Use of Commercial and Government Sources of Family Planning and Maternal and Child Health Care.

Hatcher, R. A., Trussell, J., Stewart, F., Nelson, A. L., Cates, W., Stewart, G. K., et al. (2004). Contraceptive Technology (Eighteenth revised ed.). New York, New York: Ardent Media.

Hatcher, R. A., Zieman, M., Cwiak, C., Darney, P. D., Creinin, M. D., & Stosur, H. R. (2004). A Pocket Guide to Managing Contraception. (Seventh/2004-2005 ed.). Tiger, Georgia: Bridging the Gap Foundation.

Hubacher, D., & Grimes, D. A. (2002). Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv, 57(2), 120-128.

Kaiser Network. (2005, November 22). Some doctors stop prescribing Ortho Evra birth control patch after FDA warning, Wall Street Journal reports. Retrieved December 2, 2005.

Ortho-McNeil. (2005). ORTHO EVRA full prescribing information, (norelgestromin/ethinyl estradiol transdermal system) (Revised November 2005 ed.). Raritan, New Jersey.

Pfizer. (2004). Depo-Provera prescribing information. Retrieved August 8, 2005.

Polaneczky, M., Guarnaccia, M., Alon, J., & Wiley, J. (1996). Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Fam Plann Perspect, 28(4), 174-178.

Population Council. (2004). The Population Council Joins Forces with Schering to Establish the International Contraceptive Access Foundation. Retrieved August 12, 2005.

Population Council. (2005, May 26). Jadelle Implants -- Research and Development. Retrieved August 9, 2005.

Population Reference Bureau. (2004). 2004 World Population Data Sheet: Population Reference Bureau.

Royal Women's Hospital Clinical Practice Guideline Steering Committee. (2005, May 31). Clinical Practice Guidelines: Implanon. Retrieved August 9, 2005.

Save the Children. (2005). State of the World's Mothers 2005 and Complete Mothers' Index 2005.

Schultz, I. R., Skillman, A., Nicolas, J. M., Cyr, D. G., & Nagler, J. J. (2003). Short-term exposure to 17 alpha-ethynylestradiol decreases the fertility of sexually maturing male rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem, 22(6), 1272-1280.

Shelton, J. (2001). "Pearl" for the week of January 15, 2001. Retrieved August 12, 2005.

The Economist. (2004). Pocket World in Figures (2004 ed.). London: Profile Books Ltd.

The Economist. (2005). Pocket World in Figures (2005 ed.). London: Profile Books Ltd.

The National Women's Health Information Center. (2005). Birth Control Methods. Retrieved August 2, 2005.

Trussell, J. (2004). Contraceptive failure in the United States. Contraception, 70(2), 89-96.

Vitzthum, V. J., & Ringheim, K. (2005). Hormonal contraception and physiology: a research-based theory of discontinuation due to side effects. Stud Fam Plann, 36(1), 13-32.

Wildemeersch, D., & Rowe, P. J. (2005). Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system. Contraception, 71(6), 470-473.

Wood, C. (1999). Menorrhagia: a management update. Mod Med Aust, 42, 65-75.

World Health Organization. (2001). Iron Deficiency Anaemia Assessment, Prevention, and Control: A guide for programme managers. Retrieved August 11, 2005.

World Health Organization. (2004a). Contraceptive prevalence in European countries.

World Health Organization. (2004b). Medical eligibility criteria for contraceptive use (3rd ed.). Geneva: Reproductive Health and Research, World Health Organization.

Back to Limitations of current contraceptives for women